TVRD
Tvardi Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 4 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
No thesis.
+7.34%
vs ±67.0% implied · ×0.11
shaded = implied · ▲▼ = realized
Largest filed tie
—
Tvardi Therapeutics, Inc.
0.80
+0.01 · +0.92%
post 0.80 0.00%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Slate Path CapitalSlate Path Capital | $1.3M | 31.61% | 0.00% | |
| 2 | Vanguard Capital ManagementVanguardindex-like | $654,326 | 15.46% | −0.09% | |
| 3 | American Financial GroupAmerican Financial | $424,952 | 10.04% | 0.00% | |
| 4 | UBS GroupUBS | $211,153 | 4.99% | +120.27% | |
| 5 | Silvercrest Asset Management GroupSilvercrest | $191,965 | 4.54% | 0.00% | |
| 6 | BlackRockBlackRockindex-like | $181,408 | 4.29% | −75.40% | |
| 7 | Renaissance TechnologiesRenaissance Technologies | $173,677 | 4.10% | −0.75% | |
| 8 | Geode Capital ManagementGeodeindex-like | $171,741 | 4.06% | −50.45% | |
| 9 | Morgan StanleyMorgan Stanley | $147,905 | 3.50% | +6.79% | |
| 10 | Duncan Williams Asset ManagementDuncan Williams | $120,158 | 2.84% | 0.00% | |
| 11 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $84,949 | 2.01% | −4.61% | |
| 12 | Russell Investments GroupRussell | $82,133 | 1.94% | +85.47% | |
| 13 | State StreetState Streetindex-like | $64,410 | 1.52% | −65.13% | |
| 14 | Susquehanna International GroupSusquehanna International | $63,014 | 1.49% | new | |
| 15 | AQR Capital ManagementAQR | $51,483 | 1.22% | −35.78% | |
| 16 | Northern TrustNorthern Trustindex-like | $41,489 | 0.98% | −55.51% | |
| 17 | Savant CapitalSavant Capital | $37,000 | 0.87% | new | |
| 18 | GSA Capital PartnersGSA Capital Partners | $34,000 | 0.80% | new | |
| 19 | Diadema PartnersDiadema Partners | $31,553 | 0.75% | new | |
| 20 | XTX TopcoXTX Topco | $28,249 | 0.67% | new | |
| 21 | Brown AdvisoryBrown Advisory | $21,280 | 0.50% | new | |
| 22 | SRS Capital AdvisorsSRS Capital | $20,906 | 0.49% | +32.04% | |
| 23 | Qube Research & TechnologiesQube Research & Technologies | $19,399 | 0.46% | new | |
| 24 | Persistent Asset PartnersPersistent Asset Partners | $8,081 | 0.19% | new | |
| 25 | PNC Financial Services GroupPNC Financial Services | $6,685 | 0.16% | +577.84% |
56 managers report $4.2M of Tvardi Therapeutics on form 13F for the quarter ended Jun 30 '26. 9 of them hold 80% of it; Slate Path Capital is largest at 31.61%.
No implied move.
No implied move.
Expected move
No implied move.